Method for separating and fractionating biological sample
The combination of stepwise centrifugation, density gradient centrifugation, and size exclusion chromatography addresses the limitations of existing methods by achieving high-resolution, time-efficient fractionation of biological samples, ensuring accurate analysis and reproducibility.
Patent Information
- Application Number
- PCT/JP2024/017546
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-12
- Filing Date
- 2024-05-10
- Publication Date
- 2024-11-21
AI Technical Summary
Current methods for biological sample separation and fractionation, such as centrifugation and chromatography, face limitations in resolution and time efficiency, particularly when analyzing samples with a wide range of particle sizes and densities, leading to incomplete separation and potential mixing of substances.
A method combining stepwise centrifugation, density gradient centrifugation, and size exclusion chromatography to fractionate biological samples, where each step enhances separation resolution and speed by sequentially collecting fractions based on size and density, allowing for high-resolution analysis within a short time frame.
This method enables high-resolution fractionation of biological samples with a wide range of sizes and densities, maintaining sample freshness and reproducibility, and allows for accurate analysis and comparison of substances within each fraction, improving upon the limitations of existing techniques.
Smart Images

Figure JP2024017546_21112024_PF_FP_ABST
Abstract
Description
Biological sample separation and fractionation method
[0001] The present invention relates to a method for separating and fractionating with high resolution substances and structures that constitute a biological sample collected from a human body or the like.
[0002] Humans, animals, and other organisms are organized aggregates of various substances. The substances that make up living organisms maintain an appropriate order, such as localization in appropriate locations and appropriate shapes and sizes, to achieve appropriate molecular functions within the organism. However, when this appropriate order is disrupted for some reason, it can lead to substance abnormalities and disease manifestations. For example, molecular-level pathologies in various diseases are known to involve changes in molecular localization and molecular size, such as the formation of dimers, multimers, and aggregates. Examples include the aggregation of amyloid-related proteins in Alzheimer's disease and the multimerization of pathological proteins in prion diseases. Therefore, molecular-level analyses that can accurately evaluate changes in the localization and size distribution of particles and molecules in biological samples are needed to understand disease.
[0003] The analysis of such biomolecules consists of "separation and fractionation techniques" for molecules from biological tissues and "detection techniques." As "separation and fractionation techniques," for example, centrifugation, as described in Non-Patent Document 1, has long been used to extract and prepare large intracellular components from biological tissues. Improvements to techniques with constant solution density and centrifugal force include stepwise centrifugation (see Non-Patent Document 2), which gradually changes the centrifugal force, and density gradient centrifugation (see Non-Patent Document 3), which utilizes a density gradient. Liquid chromatography is also commonly used to separate soluble molecular groups that do not precipitate even in ultracentrifugation, which performs centrifugation at ultrahigh speeds. Meanwhile, with regard to "detection techniques," dramatic advances have been made in instruments for detecting various substances, such as those used in proteomics, metabolomics, and metallomics, enabling the analysis and detection of various molecules and elements, including molecular identification, structural analysis, molecular modification analysis, and elemental composition analysis.
[0004] Harvey R. Cloten et al., "Purification of the first component of complement by zonal ultracentrifugation", Journal of Immunology, 103(4), 862-865, 1969Aikaterini Geladaki et al., "Combining LOPIT with differential ultracentrifugation for high-resolution spatial proteomics", Nature Communications, 10(1), 331m 2019T. Ford et al., "Iodixanol: a nonionic iso-osmotic centrifugation medium for the formation of self-generated gradients", Analytical Biochemistry, 220(2), 360-366, 1994
[0005] Traditionally, molecular-level analysis of biological samples has relied on microscopic analysis of tissue morphology using optical or electron microscopes, as well as classical biochemical separation and fractionation methods. However, microscopic analysis suffers from the drawback of incompleteness and quantification of observed molecules. Furthermore, biochemical separation and fractionation methods face the problem of insufficient separation resolution, since freshness is crucial for biological samples and all separation procedures must be performed within a limited time frame to maintain the structure and activity of biological components during the sample separation process.
[0006] For example, fractionation of biological samples has long been performed by centrifuging to separate the supernatant and precipitate components, followed by three repeated centrifugations at varying centrifugal forces, known as stepwise centrifugation. This allows for the isolation of nuclear components, organelle components, vesicles and macromolecules, and cytoplasmic components. Attempts have also been made to achieve finer separation by increasing the number of steps in this stepwise centrifugation method. However, increasing the number of steps in stepwise centrifugation has limited the resolution of the structures that can be separated. Density gradient centrifugation has also been used to purify viruses using a cesium chloride density gradient and extracellular vesicles and mitochondria using a sucrose density gradient.
[0007] However, when tracking and capturing all particles in biological samples, which are composed of diverse sizes and densities, existing density gradient centrifugation methods have difficulty accurately recovering all particles distributed in a continuous density gradient. Furthermore, when using liquid chromatography, which is used to separate and fractionate soluble molecular groups that do not precipitate even by ultracentrifugation, to analyze biological samples, a separation resolution high enough to separate different components into separate peak fractions is required. However, as mentioned above, freshness of biological samples is important, so time is limited. For this reason, in the case of size exclusion chromatography, which is used to measure and verify particle size, even the highly accurate long-sized columns used for particle size analysis cannot ensure sufficient separation resolution to fully separate and evaluate, for example, the monomer, dimer, and tetramer of albumin, a protein commonly found in living organisms. To improve separation resolution to accommodate biological samples containing a wide range of size components, the column length must be extended. However, extending the column length increases column pressure, necessitating a slower flow rate, which increases the time required for separation and analysis. Therefore, it is not suitable for rapid separation of biological samples.
[0008] Therefore, an object of the present invention is to provide a method for separating and fractionating all of a biological sample containing material components of a wide range of sizes with high resolution, while eliminating the problems present in the prior art and reducing the time required for separation and fractionation.
[0009] In view of the above object, the present invention provides a method for separating and fractionating a biological sample collected from a living organism into a plurality of fractions, the method comprising: a homogenizing step of adding a solvent to the biological sample to disrupt cells to prepare a cell homogenate; a first centrifugation step of centrifuging the prepared cell homogenate at a first acceleration G1 to separate it into a first supernatant component and a first pellet component; and a second centrifugation step of centrifuging the prepared cell homogenate at a (m-1)th acceleration G1, where m is an integer from 2 to n. m-1 The mth acceleration G is greater than m a stepwise centrifugation step of subjecting a centrifuge tube containing the separated (m-1)th supernatant component to an mth centrifugation treatment to separate the (m-1)th supernatant component into an mth supernatant component and an mth pellet component, and repeating this process (n-1) times; a density gradient centrifugation step of subjecting a predetermined amount of density gradient sample to density gradient centrifugation treatment, the density gradient sample being prepared by adding the mth pellet component to a density gradient reagent in a density gradient centrifugation tube such that the density is higher at the bottom than at the top; and m is a predetermined integer corresponding to the m pellet component, the density gradient sample corresponding to the m pellet component in the density gradient centrifugation tube that has been subjected to the density gradient centrifugation step is collected in amounts according to a predetermined rule from the top or bottom side, m and a chromatography step of adding the n-th supernatant component separated by the stepwise centrifugation step to a size exclusion chromatography column, and then supplying a buffer to the column at a predetermined flow rate, where b is a predetermined integer, and discharging the n-th supernatant component and the buffer as a mixture of the supernatant component and the buffer from the column as a chromatography sample, and recovering the chromatography sample discharged from the column in amounts according to a predetermined rule to fractionate the entire biological sample into b fractions, where "acceleration G" is a predetermined integer. m" means G1, G2, ..., Gn, i.e., the acceleration G in the nth centrifugation process. However, since it is not possible to distinguish whether Gm-1 means [Gm]-1 (subtracting 1 from Gm) or G[m-1] (the (m-1)th acceleration G), for convenience, "m" is written as a subscript.
[0010] In the method for separating and fractionating a biological sample, following a first centrifugation step for a homogenate prepared from a biological sample, the (m-1)th supernatant component separated in the previous centrifugation step is subjected to a stepwise centrifugation step with the acceleration being increased stepwise, and the mth pellet component separated in the stepwise centrifugation step is added to a density gradient reagent to prepare a density gradient sample, and then the density gradient sample is subjected to a density gradient centrifugation step, and then in a density gradient centrifugation recovery step, the density gradient sample is recovered in amounts according to a predetermined rule from the top or bottom side. mThe nth supernatant component is separated into n fractions, and the nth supernatant component is finally separated into b fractions by size exclusion chromatography in a chromatography step, where the resulting chromatography sample is collected in predetermined amounts according to a predetermined rule. Each of the separation and fractionation methods used in the above biological sample separation and fractionation methods has the following drawbacks when attempting to analyze the entire biological sample. Simple centrifugation aims to separate the sample into two components: a supernatant component and a pellet component, while stepwise centrifugation is suitable for coarse fractionation, such as large nuclei, medium-sized organelles, and small cytoplasm. However, stepwise centrifugation has a limit to the number of fractions that can be separated, and because it uses centrifugal force for separation, each fraction contains multiple types of substances with similar densities and sizes under the same solvent conditions, i.e., solvents with the same density. Therefore, physiologically meaningful separation is not possible. Furthermore, increasing the number of fractions obtained by stepwise centrifugation alone to improve separation accuracy requires an increased number of repeated centrifugation steps, which is extremely time-consuming and unsuitable as a fractionation method for biological samples with limited processing time. Furthermore, density gradient centrifugation requires the use of a centrifuge, which limits the sedimentation path length due to factors such as the size of the centrifuge. Furthermore, due to the use of density gradient media with varying densities, there is an optimal range depending on the size and density of the substances to be separated. Therefore, when applied to samples with a wide range of sizes, the separation resolution of the fractions to be separated decreases. Furthermore, chromatography, by its very nature, can only be used to fractionate substances of a certain size, and is not suitable for fractionating the entire biological sample.
[0011] However, in the biological sample separation and fractionation method of the present invention, the mth pellet component is obtained by roughly dividing the sample based on size, particle size, and density in the stepwise centrifugation step, and each pellet component is subjected to a density gradient centrifugation step and a density gradient centrifugation recovery step, thereby enabling fractionation with high separation resolution in a short time. Furthermore, for substances contained in the nth supernatant component that cannot be separated even in the stepwise centrifugation step, the nth supernatant component finally obtained after the stepwise centrifugation step is subjected to size exclusion chromatography, and the resulting chromatography sample is recovered in amounts according to a predetermined rule and separated into b fractions, thereby enabling fractionation with high separation resolution in a short time.
[0012] In this way, by combining a stepwise centrifugation step, a density gradient centrifugation step using density gradient centrifugation, a density gradient centrifugation recovery step, and a chromatography step using size exclusion chromatography, it is possible to fractionate a biological sample containing substances of a wide range of sizes, particle sizes, and densities thoroughly and in a short time with high separation resolution. Furthermore, a density gradient sample is prepared from the mth pellet component obtained at each step of the stepwise centrifugation step, and the density gradient sample in the density gradient centrifugation tube is subjected to a density gradient centrifugation step. The density gradient sample is then collected in the density gradient centrifugation recovery step in order from the top or bottom of the density gradient centrifugation tube. Therefore, the collection order of the fractions obtained in the density gradient centrifugation recovery step reflects information about the size of the substances contained in each fraction. Similarly, a chromatography sample is prepared from the nth supernatant component finally obtained through the stepwise centrifugation step, and the fractions are collected in order. Therefore, the collection order of the fractions obtained in the chromatography step also reflects information about the size of the substances contained in each fraction. Therefore, by analyzing the substances contained in each fraction, it is possible to obtain not only the type of substance contained in each fraction, but also information about the size of the substances based on the order in which the separated fractions were collected. Furthermore, since each fraction is collected in an amount according to a predetermined rule, under the same conditions, each substance in a biological sample will be contained in the corresponding fraction with high reproducibility, and information about size will also be highly reproducible.
[0013] In the above biological sample separation and fractionation method, x m and y are each a predetermined integer, in the density gradient centrifugation recovery step corresponding to the m pellet component, m ml equally m and in the chromatography step, the chromatography sample discharged from the column is preferably equally divided into b fractions each having y ml, and m It is even more preferable that y = y. By making the amounts of each fraction equal, quantitative comparison of the substances contained in each fraction becomes possible. For example, it becomes possible to compare which of the multiple fractions obtained in the density gradient centrifugation recovery step contains a large amount of a particular substance, or which of the multiple fractions obtained in the chromatography step contains a large amount of a particular substance.
[0014] In the above case, when using a 14 ml density gradient centrifugation tube, x m = y = 1 ml, and a m It is preferable that a=14 and b=30.
[0015] In one embodiment, the n is 3, and the centrifugation process is performed three times.
[0016] For example, the density gradient reagent may be an iodixanol solution. In this case, it is preferable that the maximum concentration of the density gradient reagent used when the (m+1)th pellet component is subjected to the density gradient centrifugation step is set to be greater than the minimum concentration of the density gradient reagent used when the mth pellet component is subjected to the density gradient centrifugation step. For example, when n is 2, the density gradient reagent is preferably formed by layering the iodixanol solution at six different concentrations. The density gradient reagent used when performing the density gradient centrifugation step on the second pellet component is layered so that the concentrations of the iodixanol solution are, from bottom to top, 35%, 30%, 25%, 22.5%, 20%, and 15%. It is even more preferable that the density gradient reagent used when performing the density gradient centrifugation step on the third pellet component is layered so that the concentrations of the iodixanol solution are, from bottom to top, 25%, 20%, 15%, 10%, 5%, and 0%.
[0017] Preferably, the chromatography step uses a plurality of columns connected in series, for example, two columns connected in series.
[0018] In one embodiment, the fractions obtained in each step can be automatically separated and collected by a fraction collector.
[0019] According to the biological sample separation and fractionation method of the present invention, by combining a stepwise centrifugation step, a density gradient centrifugation step using density gradient centrifugation, a density gradient centrifugation recovery step using density gradient centrifugation, and a chromatography step using size exclusion chromatography, it is possible to fractionate a biological sample containing substances of a wide range of sizes, particle sizes, and densities thoroughly and with high separation resolution in a short time. Furthermore, the collection order of the multiple fractions obtained in each density gradient centrifugation recovery step and the chromatography step reflects information about the size of the substances contained in each fraction. Therefore, by analyzing the substances contained in each fraction, it is possible to obtain information about the type of substances contained in each fraction as well as the size of the substances based on the order in which the separated fractions were collected. Furthermore, since each fraction is collected in an amount according to a predetermined rule, under the same conditions, each substance in the biological sample will be contained in the corresponding fraction with high reproducibility. This makes it possible to analyze the size distribution and quantitative comparison of substances contained in the biological sample, such as determining which sizes are most common.
[0020] 1 is a flowchart showing the procedure of a biological sample separation and fractionation method according to the present invention. It is an explanatory diagram schematically showing one example of the procedure shown in Fig. 1. It is a graph showing the distribution of the abundance of mitochondrial constituent proteins contained in each fraction obtained by the density gradient centrifugation recovery step of the biological sample separation and fractionation method shown in Fig. 1. It is a graph showing the distribution of the abundance of various proteins contained in each fraction separated by the chromatography step of the biological sample separation and fractionation method shown in Fig. 1. It is a graph showing a size calibration curve showing the correspondence between each fraction separated by the chromatography step of the biological sample separation and fractionation method shown in Fig. 1 and the size of the particles contained therein. It is a graph showing the distribution of all sizes of prion proteins contained in each fraction, based on all fractions separated by the biological sample separation and fractionation method shown in Fig. 1.
[0021] The method for separating and fractionating a biological sample according to the present invention will be described below with reference to the drawings.
[0022] First, the overall flow of the method for separating and fractionating a biological sample according to the present invention will be described with reference to FIGS.
[0023] First, a homogenization process is performed in which approximately 100 mg to 1 g of a biological sample, such as tissue or cells collected from a living organism, is homogenized (cell disruption) for approximately 5 minutes to prepare a cell homogenate (step ST1). This releases intracellular organelles and macromolecules from the tissues and cells of the biological sample. Next, the centrifuge tube containing the cell homogenate prepared in step ST1 is subjected to a stepwise centrifugation process. Specifically, the cell homogenate prepared in step ST1 is subjected to a first centrifugation process at an acceleration G1 under atmospheric pressure in a low-temperature environment of approximately 2 to 4°C, separating it into a first pellet component P1 and a first supernatant component S1 (step ST2). In the centrifugation process, centrifugal force due to acceleration is applied to the centrifuge tube, and large, heavy particles in the centrifuge tube settle faster than small, light particles, thereby roughly separating the first pellet component P1 and the first supernatant component S1. For example, by performing centrifugation for about 5 minutes under conditions of an acceleration G1 of about 1500 G, the cell homogenate can be separated into a first pellet component P1 and a first supernatant component S1. The first pellet component P1 obtained in step ST2 is separated and recovered as a nuclear fraction N. Meanwhile, in step ST3, the first supernatant component S1 separated in step ST2 is subjected to a second centrifugation process at a centrifugal acceleration G2 greater than the centrifugal acceleration G1 in the centrifuge tube containing the first supernatant component S1, to further separate it into a second pellet component P2 and a second supernatant component S2. Thereafter, the supernatant component obtained in the previous step is centrifuged at an acceleration greater than that of the previous centrifugation process, and further separated into a pellet component and a supernatant component, a predetermined number of times. That is, in step ST3, when m is an integer from 2 to n (m = 2, ..., n), the (m-1)th supernatant component S obtained in the previous (m-1)th centrifugation process is m-1 In contrast, the acceleration G in the (m-1)th centrifugation process m-1 Acceleration G greater than m The mth centrifugation treatment is carried out to obtain the mth pellet component P m and the mth supernatant component S mThis process of separating the particles into pellets and the particles into pellets is repeated until m=n, i.e., until the nth centrifugation process is performed. Therefore, in step ST3, (n-1) pellet components are obtained.
[0024] The stepwise centrifugation process can only roughly separate the pellet and supernatant components. Furthermore, since the centrifugal acceleration is increased stepwise during the stepwise centrifugation process, the pellet component obtained earlier contains relatively large and heavy substances that are prone to settling, while the pellet component obtained later contains relatively small and light substances that are difficult to settling. Therefore, in order to achieve sufficient separation resolution through centrifugation alone, multiple centrifugation processes are required during the stepwise centrifugation process. However, freshness is important for biological samples. In order to maintain the structure and activity of biological components during the separation and fractionation process and to suppress oxidation and decomposition reactions of molecular groups, it is desirable to complete the separation and fractionation process of biological samples (such as tissues and cells), i.e., the entire process from disruption of the biological sample to all separation and recovery steps, in a biological solution under low-temperature conditions of 2 to 4°C within 10 hours, and multiple centrifugation processes are not practical. Furthermore, in principle, centrifugation is effective for separation when the sedimentation coefficient, which is an index of the ease of sedimentation due to gravity, is significantly different, and stepwise centrifugation is also suitable for separating into roughly three groups, such as nuclei with large particle sizes, organelles with medium particle sizes, and cytoplasm with fine particles, but is not suitable for separation when the difference in sedimentation coefficient is small. For this reason, the pellet components contain a large number of substances, and the separation is not physiologically meaningful. Therefore, in the biological sample separation and fractionation method according to the present invention, the mth pellet component P, excluding the first pellet component P1, is selected from the pellet components obtained at each stage of the stepwise centrifugation process. m The mixture is subjected to density gradient centrifugation to obtain the m-th pellet component P m The particles are separated further by the difference in density of the substances contained therein.
[0025] It is known that the stepwise centrifugation method can separate the sample into roughly three groups by performing three stepwise centrifugations: nuclear components such as nuclei and tissue fragments, large organelles, and small cytoplasm such as vesicles. Considering that further separation and fractionation is performed in the density gradient centrifugation step at a later stage of the biological sample separation and fractionation method according to the present invention, and that it is desirable to complete the entire separation and fractionation process in a short period of time as described above, it can be said that separation into these three groups is sufficient in the stepwise centrifugation step. Therefore, in the biological sample separation and fractionation method according to the present invention, n is preferably 3 or more, and more preferably n = 3. In the biological sample separation and fractionation method according to the present invention, when n = 3 and three centrifugation steps including step ST2 are performed, the first pellet component P1 generally contains nuclear components such as nuclei and tissue fragments, the second pellet component P2 contains large organelles (cellular organelles), and the third pellet component contains small organelles, vesicles, macromolecules, etc.
[0026] Among the pellet components obtained at each stage of the stepwise centrifugation process of step ST3, the m-th pellet component P excluding the first pellet component P1 m In step ST4, after the density gradient centrifugation step, the sample is collected from the top or bottom in a predetermined amount according to a predetermined rule. m The fractions are separated and collected. m is a predetermined integer corresponding to the mth pellet component. In detail, each pellet component P obtained by stepwise centrifugation steps (excluding the first centrifugation step) in a density gradient reagent in which a density gradient is formed so that the density is higher at the bottom than at the top in a density gradient centrifugation tube is mis added to prepare a predetermined amount of density gradient sample. The maximum value of the concentration range of the density gradient reagent used when performing the density gradient centrifugation step on the (m+1)th pellet component is set to be greater than the minimum value of the concentration range of the density gradient reagent used when performing the density gradient centrifugation step on the mth pellet component. Furthermore, the amount of density gradient sample to be prepared may be determined appropriately, taking into account the capacity of the density gradient centrifugation tube to be used, so as to obtain the total amount of fractions to be recovered. The density gradient centrifugation tube containing the density gradient sample is subjected to a centrifugation process at a predetermined acceleration using a centrifuge device. As a result, the mth pellet component P m The multiple substances contained in the m-th pellet component P each settle to a predetermined position in the density gradient reagent according to their density, and are separated. At this time, substances with higher densities are located closer to the bottom. m When the density gradient centrifugation step for is completed, in the density gradient centrifugation recovery step, for example, a hole is made in the bottom of the density gradient centrifugation tube, and a buffer (i.e., 0% density gradient reagent) is added to the top surface of the density gradient sample in an amount equal to the recovery flow rate, while the density gradient sample in the density gradient centrifugation tube is discharged sequentially from the bottom side at a predetermined recovery flow rate, and the density gradient sample is discharged in a predetermined amount according to a predetermined rule. m The density gradient centrifugation recovery step may be performed, for example, by inserting an aspirator into the density gradient sample from the top of the density gradient centrifugation tube, sequentially aspirating the density gradient sample from the bottom, and recovering each fraction in a predetermined amount according to a predetermined rule. The amount of density gradient sample recovered in each fraction includes the excluded volume of the flow channel used to discharge the density gradient centrifugation tube and the volume of buffer added during recovery. The amount of each fraction may be determined appropriately based on the diameter and sedimentation length of the density gradient centrifugation tube used to obtain physiologically meaningful fractions. For example, when a centrifuge tube with a sedimentation path length of 9 to 10 cm and a capacity of 14 ml is used as the density gradient centrifugation tube, the amount of each fraction is preferably approximately 1 ml.
[0027] When the density gradient centrifugation recovery process is performed using the procedure described above, the density gradient samples are sequentially discharged from the bottom of the density gradient centrifuge tube after centrifugation. Therefore, the density, i.e., size, of the substances contained in each fraction decreases in order of collection. Therefore, it is possible to obtain information about the size of the target substance contained in each fraction from the order in which the fractions are collected. Furthermore, because each density gradient sample is separated into each fraction in amounts according to a predetermined rule, nuclear substances contained in each density gradient sample are reproducibly separated into corresponding fractions under the same conditions. This makes it possible to compare the size of the substances contained in each fraction based on the order in which the fractions are collected.
[0028] When a hole is drilled in the bottom of a density gradient centrifugation tube and the density gradient sample is discharged from the bottom of the density gradient centrifugation tube, the hole in the bottom of the density gradient centrifugation tube can be connected to a fraction collector via a relay tube, and the density gradient sample can be automatically separated and collected in predetermined amounts by the fraction collector. This allows the density gradient sample subjected to the density gradient centrifugation process to be separated and collected efficiently in accurate amounts and in a short time. In particular, to obtain information about the size of substances contained in each fraction based on the order in which each fraction is collected, it is necessary for each substance contained in the density gradient sample to be collected in a corresponding fraction with good reproducibility, and accurate fractionation is important. From this perspective, it is preferable to separate and collect the density gradient sample subjected to the density gradient centrifugation process using a fraction collector.
[0029] However, the density gradient centrifugation recovery process is not limited to the above procedure, as long as the order in which each fraction is recovered correlates with the density, i.e., size, of the substances contained in each fraction. For example, the density gradient centrifugation recovery process may involve inserting an aspirator into the top of the density gradient centrifuge tube, aspirating the density gradient sample sequentially from the top, and recovering the sample in a predetermined amount from the top. In this case, the density gradient sample is recovered sequentially from the top of the density gradient centrifuge tube that has been centrifuged. Therefore, the density, i.e., size, of the substances contained in each fraction increases in the order in which they are removed, as opposed to when the samples are recovered from the bottom. Therefore, to ensure that the size of the substances contained in each fraction decreases in the order in which they are arranged, the fractions may be arranged in reverse order of their collection.
[0030] Although known density gradient reagents such as cesium chloride and sucrose can be used, it is preferable to use iodixanol, which does not affect the osmotic pressure of biological samples. The density gradient initially formed may have a continuous or stepwise change in density. In the case of a stepwise change in density, the density gradient can be formed by placing the highest density gradient reagent at the bottom of the density gradient centrifugation tube and layering density gradient reagents with lower densities toward the top. When iodixanol is used as the density gradient medium, even if the density gradient reagents are layered, a continuous density gradient in which the density changes continuously during the centrifugation process is obtained. Density gradient centrifugation tubes are generally those with a sedimentation path length of about 5 cm and a capacity of about 5 ml, those with a sedimentation path length of about 9 to 10 cm and a capacity of about 14 ml, and those with a sedimentation path length of about 9 to 10 cm and a capacity of about 17 to 40 ml. However, in accordance with the principles of centrifugation, the longer the sedimentation length, the greater the difference in sedimentation velocity, resulting in higher separation resolution, and the narrower the tube diameter, the smaller the throughput, shortening the time required for separation and recovery, i.e., improving recovery efficiency. Therefore, in terms of the balance between separation resolution and recovery efficiency, a thin and long density gradient tube is desirable, and it is preferable to use a density gradient centrifugation tube with a sedimentation path length of about 9 to 10 cm and a capacity of about 14 ml.
[0031] mth pellet component P m The volume of all fractions in the density gradient centrifugation recovery step corresponding to the same x m ml is preferable. This is because the analytical results between each fraction, for example, the quantitative comparison of the substances contained in each fraction, can be made between each fraction. For example, it is possible to compare which of the multiple fractions obtained in the density gradient centrifugation recovery step contains a large amount of a particular substance. For the same reason, it is preferable to compare the m-th pellet component P m The volume of all fractions in the density gradient centrifugation recovery step performed for (m=2, ..., n) is the same x m It is even more preferable that x ml = x ml. When a density gradient centrifugation tube with a sedimentation path length of about 9 to 10 cm and a capacity of about 14 ml is used and the volume of all fractions obtained in the density gradient centrifugation recovery step is made equal, the volume of each fraction is preferably 1 ml. By determining the volume of each fraction in this way, it is possible to ensure sufficient separation resolution to distinguish the type of substance to be analyzed.
[0032] After the nth centrifugation step is completed in step ST3 (step ST5), the nth supernatant component Sn is subjected to size exclusion chromatography, and the resulting chromatography sample is separated into b fractions in accordance with a predetermined rule and collected (step ST6). Here, b is a predetermined integer. Specifically, the nth supernatant component Sn separated by the nth centrifugation step is added to a size exclusion column using an autosampler or the like, and then buffer is supplied to the size exclusion column at a predetermined flow rate. The nth supernatant component Sn flows through the gaps in the packing material in the size exclusion column together with the buffer, and the substances contained in the nth supernatant component Sn are discharged from the size exclusion column together with the buffer as a chromatography sample over a period of time corresponding to their size. The chromatography sample containing the nth supernatant component Sn is the portion of the size exclusion column that remains after the buffer equivalent to the exclusion volume of the size exclusion column has been discharged from the size exclusion column until the buffer equivalent to the column volume has been discharged. The chromatography sample discharged from the size exclusion separation column is separated into fractions in the order in which it is discharged, and collected in amounts that follow a predetermined rule.
[0033] Size-exclusion columns used in size-exclusion chromatography are filled with a packing material with many pores. Smaller molecules penetrate the pores of the packing material as they flow, resulting in longer time until they are discharged from the size-exclusion column. This characteristic, which allows molecules of different sizes to be discharged, is utilized to separate substances. If a chromatography sample is separated into fractions in amounts according to a predetermined rule in the order in which it is discharged from the size-exclusion column and collected, larger substances contained in the chromatography sample will be collected in the earlier fractions, while smaller substances will be collected in the later fractions. Therefore, information on the size of the substances contained in each fraction can be obtained from the collection order. Furthermore, because the chromatography sample is separated into fractions in amounts according to a predetermined rule, under the same conditions, each substance contained in the chromatography sample will be separated into corresponding fractions with good reproducibility, making it possible to compare the size of the substances contained in each fraction based on the order in which the fractions were collected.
[0034] The separation and collection of the chromatography sample discharged from the size exclusion column is preferably performed using a fraction collector, with the size exclusion column and the fraction collector connected by a relay tube. This allows the chromatography sample discharged from the size exclusion column to be separated and collected efficiently in an accurate amount and in a short time. In particular, in order to obtain information about the size of the substances contained in each fraction based on the order in which the fractions are collected, it is necessary for each substance contained in the chromatography sample to be collected in a corresponding fraction with good reproducibility, and accurate fractionation is important. From this perspective, it is preferable to separate and collect the chromatography sample discharged from the size exclusion column using a fraction collector.
[0035] Furthermore, because the time it takes for a substance contained in the nth supernatant component to be discharged from the size exclusion column varies based on the above-described principle, increasing the sample migration distance, i.e., the length of the size exclusion column, is preferable to improve separation resolution. However, while size exclusion chromatography requires the buffer to be forcibly pumped into the size exclusion column, there is an upper limit to the pressure that can be applied to the size exclusion column due to the strength of the size exclusion column. Therefore, there is also an upper limit to the flow rate of the buffer flowing through the size exclusion column. Increasing the length of the size exclusion column to improve separation resolution increases the pressure required to pump the buffer into the size exclusion column, which in turn increases the pressure acting on the size exclusion column, making it necessary to reduce the flow rate of the buffer into the size exclusion column. This increases the time required for the chromatography process, hindering rapid separation of the biological sample. For this reason, it is preferable to connect multiple size exclusion columns in series in the chromatography process of the biological sample separation and fractionation method of the present invention. This prevents an increase in pressure acting on one size exclusion column, maintains the flow rate, and prevents an increase in processing time, while improving separation resolution. In addition, it is preferable to use a size exclusion column that can withstand high pressure in order to maximize the buffer flow rate.
[0036] Furthermore, when size exclusion separation columns are connected in series, the path through which the chromatography sample flows becomes longer, and therefore the time required for all of the substances contained in the nth supernatant component added to the first size exclusion separation column to be discharged from the last size exclusion separation column becomes longer. Freshness is important for biological samples, and considering the balance between the desirability of completing the process as quickly as possible and the desirability of ensuring high separation resolution, it is preferable to perform the chromatography step by connecting two size exclusion separation columns, each 30 cm long, in series.
[0037] It is preferable that the volume of each fraction in the chromatography step according to the predetermined rule is the same y ml. This is because, as in the density gradient centrifugation recovery step, analysis results between each fraction, for example, quantitative comparison of the substances contained in each fraction, can be made between each fraction. For example, it becomes possible to compare which of the multiple fractions obtained in the chromatography step contains a larger amount of a particular substance.
[0038] In the density gradient centrifugation recovery step, when the volumes of the fractions recovered from all pellet components except the first pellet component are all the same (x ml), and when the volumes of the fractions recovered from the supernatant component in the chromatography step are all the same (y ml), it is preferable to set x = y. This significantly simplifies the analytical process and also makes it easier to compare the quantities of substances contained in all fractions obtained by the biological sample separation and fractionation method of the present invention.
[0039] Thus, in the biological sample separation and fractionation method of the present invention, the biological sample is first roughly divided into a plurality of pellet components and a supernatant component by stepwise centrifugation according to the size of the substances contained in the biological sample, and each pellet component containing a limited range of substances is separated into a plurality of fractions according to density by density gradient centrifugation, except for the pellet component obtained by the first centrifugation, and recovered. Finally, the remaining supernatant component is separated into a plurality of fractions according to size by size exclusion chromatography and recovered. In this way, all substances contained in the biological sample are separated and fractionated into [1 + (n - 1) x a + b] fractions (step ST7). Furthermore, in the stepwise centrifugation step, the acceleration during centrifugation is increased stepwise, so that the first pellet component S1 obtained by the first centrifugation is larger than the mth pellet component S obtained by the subsequent centrifugation. m Therefore, the m-th pellet component P mThe range of sizes and weights of the substances contained in the nth supernatant component Sn is narrower than that of the initial biological sample. Therefore, when performing density gradient centrifugation of each pellet component, high separation resolution can be ensured even using a short density gradient centrifugation tube. Furthermore, using a short density gradient centrifugation tube enables separation and fractionation in a short time. As a result, high separation resolution can be ensured in a short time within a range that maintains the freshness of the biological sample. Note that, since the size exclusion chromatography process is performed on the nth supernatant component Sn finally obtained by the stepwise centrifugation process, the nth supernatant component Sn contains only sufficiently small substances, so there is no risk of clogging the size exclusion separation column.
[0040] In addition, using a fraction collector for separation and fractionation not only significantly reduces the time required for separation and fractionation, but also enables accurate fractionation. When accurate fractionation is performed, each substance will be reproducibly contained in the corresponding fraction under the same conditions. Furthermore, when fractionation is performed with sufficient separation resolution, substances of different sizes will be contained in different fractions. As a result, different fractions reveal different sizes of substances contained in each fraction, making it possible to analyze whether the same molecule contains more monomers or more dimers.
[0041] In the above explanation, "acceleration G m " means G1, G2, ..., Gn, that is, the acceleration G in the n-th centrifugation process, but since it is not possible to distinguish whether Gm-1 means [Gm]-1 (subtracting 1 from Gm) or G[m-1] (the (m-1)th acceleration G), for convenience, "m" is written as a subscript. "The m-th pellet component P m " and "mth supernatant component S m The same applies to the notation ".
[0042] Next, one embodiment of the method for separating and fractionating a biological sample according to the present invention will be described.
[0043] First, approximately 100 mg to 1 g of a biological sample, such as tissue collected from a living organism, is disrupted with a solvent for approximately 5 minutes using a homogenizer to solubilize the biological sample and prepare a cell homogenate. Next, the centrifuge tube containing the cell homogenate is subjected to three stepwise centrifugation steps (centrifugation steps) at atmospheric pressure in a low-temperature environment of 2 to 4°C. Specifically, the first centrifugation step involves two 5-minute refrigerated centrifugations at an acceleration of 1500 G; the second centrifugation step involves 20 minutes of refrigerated centrifugation at an acceleration of 10,000 G; and the third centrifugation step involves 60 minutes of refrigerated centrifugation at an acceleration of 100,000 G. By performing centrifugation in this manner, the stepwise centrifugation steps can be completed in approximately 2 hours, including preparation and recovery work. A 14 ml capacity centrifuge tube with a sedimentation path length of approximately 9-10 ml is used.
[0044] In the first centrifugation step, the cell homogenate is separated into a first pellet component P1 and a first supernatant component S1. The first pellet component P1 obtained in the first centrifugation step mainly contains nuclei and cell debris and is collected as a nuclear component N1. Meanwhile, the first supernatant component P1 obtained in the first centrifugation step is placed in a centrifuge tube and further separated into a second pellet component P2 and a second supernatant component S2 by a second centrifugation step under the above-mentioned conditions. Furthermore, the second supernatant component P2 obtained in the second centrifugation step is placed in a centrifuge tube and further separated into a third pellet component P3 and a third supernatant component S3 by a third centrifugation step under the above-mentioned conditions. Thus, in the stepwise centrifugation steps, the biological sample is separated into a first pellet component P1, a second pellet component P2, a third pellet component P3, and a third supernatant component S3.
[0045] Next, the second pellet component P2 and the third pellet component P3 are subjected to a density gradient centrifugation step. First, for the second pellet P2, a predetermined amount of a first density gradient sample is prepared by stacking, from the bottom, 1 ml of 35% iodixanol, 200 μl of 50% iodixanol added to 100 μl of the second pellet component P2, 1 ml of 30% iodixanol, 2 ml of 25% iodixanol, 2 ml of 22.5% iodixanol, 2 ml of 20% iodixanol, and 2 ml of 15% iodixanol in a first density gradient centrifugation tube having a sedimentation path length of approximately 9-10 ml and a volume of 14 ml. The prepared first density gradient sample is centrifuged for two hours at an acceleration of 100,000 G under atmospheric pressure in a low-temperature environment of 2 to 4°C. After completion of the centrifugation process for the first density gradient centrifugation tube containing the centrifuged first density gradient sample, a hole is drilled in the bottom of the first density gradient centrifugation tube, a fraction recovery system is connected to the bottom of the first density gradient centrifugation tube, and a peristaltic pump is connected downstream of the fraction recovery system. To prevent air contamination, a buffer (i.e., 0% density gradient reagent) is added to the top surface of the first density gradient sample at a rate of 1 ml / min, while the first density gradient sample in the first density gradient centrifugation tube is aspirated sequentially from the bottom at a flow rate of 1 ml / min. Alternatively, without drilling a hole in the bottom of the first density gradient centrifugation tube, an aspirator may be inserted from the top of the first density gradient centrifugation tube to aspirate the first density gradient sample sequentially from the bottom. The aspirated first density gradient sample is separated into 1 ml portions by a fraction collector connected downstream of the peristaltic pump, and is then collected into 14 fractions, designated L1 to L14. The first density gradient sample collected in fractions L1 to L14 includes the excluded volume of the flow path for discharging the sample from the density gradient centrifugation tube and the buffer added during collection. Fractions L1 to L14 primarily contain particles of a size similar to that of organelles. The fractions L1 to L14 are designated in the order in which they were collected from the bottom of the first density gradient centrifugation tube.
[0046] The first density gradient sample may be collected from the first density gradient centrifuge tube by inserting an aspirator into the top of the first density gradient centrifuge tube and sequentially aspirating the first density gradient sample from the top, followed by separating and collecting fractions in predetermined amounts from the top according to a predetermined rule. In this case, the first density gradient sample is collected sequentially from the top of the density gradient centrifuge tube that has been centrifuged. Therefore, the density, i.e., size, of the substances contained in each fraction increases in the order of collection, as opposed to collection from the bottom. Therefore, to ensure that the size of the substances contained in each fraction decreases in the order of fraction arrangement, fractions can be separated and collected in reverse order, from fraction L14 to fraction L1, as opposed to collection of the first density gradient sample from the bottom.
[0047] Similarly, for the third pellet component P3, iodixanol was used as the density gradient solvent, and a second density gradient centrifugation tube with a sedimentation path length of approximately 9-10 ml and a volume of 14 ml was prepared. From the bottom (lower layer), 1 ml of 25% iodixanol, 2 ml of 20% iodixanol, 400 μl of 25% iodixanol plus 100 μl of the third pellet component P3, 2 ml of 15% iodixanol, 2 ml of 10% iodixanol, 2 ml of 5% iodixanol, and 1.5 ml of 0% iodixanol were layered in this order to prepare a predetermined amount of second density gradient sample. The prepared second density gradient sample was centrifuged for 2 hours at an acceleration of 100,000 G under atmospheric pressure in a low-temperature environment of 2 to 4 ° C. After the centrifugation process for the second density gradient centrifugation tube containing the centrifuged second density gradient sample is completed, a hole is made in the bottom of the second density gradient centrifugation tube using a fraction recovery system, the fraction recovery system is connected to the bottom of the second density gradient centrifugation tube, and a peristaltic pump is connected downstream of the fraction recovery system. To prevent air from getting mixed in, a buffer (i.e., 0% density gradient reagent) is added at a rate of 1 ml / min to the top surface of the second density gradient centrifugation tube, and the second density gradient sample in the second density gradient centrifugation tube is aspirated sequentially from the bottom at a flow rate of 1 ml / min. As with the first density gradient centrifugation tube, a hole may not be made in the bottom of the second density gradient centrifugation tube, and an aspirator may be inserted from the top of the second density gradient centrifugation tube to aspirate the second density gradient sample sequentially from the bottom. The aspirated second density gradient sample is separated into 1 ml portions by a fraction collector connected downstream of the peristaltic pump, and is then collected into 14 fractions, M1 to M14. The second density gradient sample collected in fractions M1 to M14 includes the excluded volume of the flow channel used to discharge the sample from the density gradient centrifugation tube, as well as the buffer added during collection. Fractions M1 to M14 primarily contain medium-sized particles such as small organelles, vesicles, and macromolecules. Fractions M1 to M14 are named in the order in which they were collected from the bottom of the second density gradient centrifugation tube.
[0048] As with the first density gradient centrifugation tube, the second density gradient sample may be recovered from the second density gradient centrifugation tube by inserting an aspirator into the top of the second density gradient centrifugation tube and sequentially aspirating the second density gradient sample from the top, followed by separating and recovering aliquots from the top according to a predetermined rule. In this case, the second density gradient sample is recovered sequentially from the top of the centrifuged second density gradient centrifugation tube. Therefore, in contrast to recovering the second density gradient sample from the bottom, the density, i.e., size, of the substances contained in each fraction increases in the order of removal. Therefore, to ensure that the size of the substances contained in each fraction decreases in the order of fraction arrangement, fractions can be separated and recovered in reverse order, from fraction L14 to fraction L1, as opposed to recovering the second density gradient sample from the bottom.
[0049] Processing of the second density centrifugation tube and the third density centrifugation tube can be carried out in parallel, so by following the procedure described above, the density gradient centrifugation process and density gradient centrifugation recovery process can be completed in approximately four hours, including preparation work and recovery work.
[0050] The third supernatant component finally obtained by the third centrifugation step is subjected to a chromatography step. First, approximately 500 μl of the third supernatant component S3 obtained by the third centrifugation step is added to two size exclusion columns (capable of withstanding high pressures of 1.0 MPa or more) connected in series (hereinafter simply referred to as the "series size exclusion columns"), each with an inner diameter of 10 mm, a length of 300 mm, and a column volume of 24 ml. After this, buffer is supplied to the series size exclusion columns at a flow rate of 0.5 ml / min. The volume of the chromatography sample, consisting of the buffer discharged from the size exclusion columns and the substances contained in the third supernatant component, is determined from the point at which the buffer equivalent to the excluded volume of the series size exclusion columns is discharged to the point at which the buffer equivalent to the column volume of the series size exclusion columns is discharged. In this example, the chromatography sample is 30 ml. This 30 ml chromatography sample is separated into 1 ml portions using a fraction collector, and the 30 fractions, S1 to S30, are collected. Fractions S1 to S30 contain small cytoplasmic matter, etc. Fractions S1 to S30 correspond to the order in which they were discharged from the size exclusion column.
[0051] In this way, a total of 59 fractions are obtained: N1, L1 to L14, M1 to M14, and S1 to S30. These 59 fractions are necessary and sufficient for detailed evaluation of the localization distribution of various organelles of different sizes and types, as well as changes in particle and molecular size. Furthermore, with the above-described method, all separation and fractionation processes can be completed within 10 hours, which is sufficient to maintain the freshness of the biological sample. Furthermore, fractions L1 to L14, M1 to M14, and S1 to S30 are arranged in this order, with the size of the substances contained in each fraction decreasing in size.
[0052] Figure 3 shows the results of an analysis performed on fractions L1-L14 and M1-M14 obtained by the density gradient centrifugation step and density gradient centrifugation recovery step performed on the second pellet P2 and the third pellet P3 using the above-mentioned method. This graph shows the distribution of mitochondrial protein abundance. In the graph shown in Figure 3, the horizontal axis represents fractions L1-L14 recovered from the first density gradient sample derived from the second pellet component P2 obtained by the second centrifugation step, and fractions M1-M14 recovered from the second density gradient sample derived from the third pellet component P3 obtained by the third centrifugation step, arranged in order of collection. The horizontal axis represents the particle size index contained in each fraction, with particle size decreasing from left to right in the figure. The vertical axis represents the relative mass spectrometer signal intensity for each fraction, with the maximum signal intensity obtained by mass spectrometer measurement of the target protein being set at 100. In Figure 3, ○ represents the measurement results for the mitochondrial protein UQCRC2, ■ represents the mitochondrial protein COX6, △ represents the mitochondrial protein COX5, and black ◇ represents the measurement results for the mitochondrial protein TOMM70. For each mitochondrial protein, the signal intensity peaks in different fractions, and it has been detected that the same protein exists in various sizes. Furthermore, if the number of fractions is reduced to half, i.e., 7, for various mitochondrial proteins, fractions L5 and L6 and fractions L7 and L8 may each be combined into a single fraction, which may prevent the two peaks shown in Figure 3 from being observed. Therefore, in the density gradient centrifugation recovery step, m It is preferable that a is ≧7, m It is more preferable to set the value to ≧14.
[0053] Figure 4 shows the results of an analysis performed on fractions S1-S30 obtained by the chromatography step performed on the third supernatant component S3 using one of the above-mentioned methods. It is a graph showing the distribution of the abundance of several substances contained in the supernatant component S3 derived from a biological sample. In the graph shown in Figure 4, the horizontal axis represents fractions S1-S30 recovered from the chromatography sample derived from the third supernatant component S3 obtained by the third centrifugation step, arranged in order of collection. The horizontal axis represents an index of the particle size contained in each fraction, with particle size decreasing from left to right in the figure. The vertical axis represents the relative value of the mass spectrometer signal intensity for each fraction, with the maximum signal intensity obtained by mass spectrometer measurement of the target protein being set at 100. In Figure 4, ▲ represents the measurement results for albumin, black ◇ represents ribosome-binding protein, □ represents ferritin heavy chain, ● represents ferritin light chain, ▲ represents fructose-bisphosphate aldolase C, and dashed □ represents small nuclear ribonucleoprotein F.
[0054] Figure 5 is a graph of a size calibration curve showing the correlation between each fraction S1 to S30 obtained in the chromatography process using standard substances of known size and the molecular weight of the substances contained therein. The horizontal axis shows the order in which each fraction S1 to S30 obtained in the chromatography process was collected, and the vertical axis shows the molecular weight in common logarithm. If a size calibration curve such as that shown in Figure 5 is prepared in advance, it becomes possible to estimate the size of the substances contained in each fraction S1 to S30 from the results shown in Figure 4. The numbers written near each peak in Figure 4 are the molecular weight of the corresponding fraction determined from such a size calibration curve.
[0055] As can be seen from Figure 4, the signal intensity peaks for each substance in different fractions, indicating accurate separation and recovery. Also, in Figure 4, when the number of fractions recovered in the chromatography step is 30, fructose bisphosphate aldolase C peaks in fraction 19, and albumin peaks in fraction S20. The size calibration curves shown in Figure 5 indicate that their respective molecular weights are 158 kDa and 69 kDa. If the number of fractions in the chromatography step is halved to 15, the substances separated into fractions S19 and S20 in Figure 4 are separated into a single fraction, making it impossible to detect a change in size of twice the amount of a protein around 70 kDa. Furthermore, if the number of fractions in the chromatography step is reduced to one-third, i.e., 10, the substances separated into fractions S19 to S21 in the case shown in Figure 4 will be separated into a single fraction, and the molecular groups in the range of approximately 158 kDa to 20 kDa will all be treated as having the same size, making it impossible to obtain accurate size information. Therefore, in the chromatography step, b must be at least 10, preferably 15, and more preferably 30.
[0056] Figure 6 is a graph showing the results of an analysis of the size distribution of prion protein in the brain, performed based on fractions L1 to L14, fractions M1 to M14, and fractions S1 to S30 obtained by the above-described method. In the graph shown in Figure 4, the horizontal axis represents fractions L1 to L14, fractions M1 to M14, and fractions S1 to S30 obtained by the biological sample separation and fractionation method of the present invention, arranged in the order of collection, and corresponds to an index of the size of particles contained in each fraction, with particle size decreasing from left to right in the figure. The vertical axis represents the relative value of the mass spectrometer signal intensity for each fraction, when the maximum signal intensity obtained by mass spectrometer measurement of the target prion protein is set to 100. The graph shown in Figure 6 reveals that prion protein exists in the brain in various sizes and multimerizes, and that quantitative comparison by size is possible. By performing the above-described analysis, it will be possible to distinguish, for example, between the brains of healthy patients and those of patients with Alzheimer's disease or prion disease, which are thought to be caused by the formation of multimers or aggregates, and this information can be useful for diagnosis, etc.
[0057] Although the biological sample separation and fractionation method according to the present invention has been described above with reference to the illustrated embodiments, the present invention is not limited to the described embodiments. For example, in the described embodiment, three centrifugation steps are performed in the stepwise centrifugation step, but two or four or more centrifugation steps are also possible. Furthermore, in the density gradient centrifugation recovery step for the second pellet component and the third pellet component, recovery is performed in 14 fractions, but the number of fractions may be fewer or more than 14. Similarly, in the chromatography step, recovery is performed in 30 fractions, but the number of fractions may be fewer or more than 30.
Claims
1. A method for separating and fractionating a biological sample collected from a living organism into a plurality of fractions, comprising: a homogenizing step of preparing a cell homogenate by adding a solvent to the biological sample to disrupt cells; a first centrifugation step of subjecting the prepared cell homogenate to a centrifugation process at a first acceleration G1 to separate the cell homogenate into a first supernatant component and a first pellet component; and a second centrifugation step of subjecting the cell homogenate to a centrifugation process at an (m-1)th acceleration G, where m is an integer from 2 to n. m-1 The mth acceleration G is greater than m a stepwise centrifugation step of subjecting a centrifuge tube containing the separated (m-1)th supernatant component to an mth centrifugation process to separate the (m-1)th supernatant component into an mth supernatant component and an mth pellet component, and repeating this process (n-1) times; a density gradient centrifugation step of subjecting a predetermined amount of density gradient sample prepared by adding the mth pellet component to a density gradient reagent in a density gradient centrifugation tube in which the density is higher at the bottom than at the top, to a density gradient centrifugation process; m is a predetermined integer corresponding to the m pellet component, the density gradient sample corresponding to the m pellet component in the density gradient centrifugation tube that has been subjected to the density gradient centrifugation step is collected in a predetermined amount from the top or bottom side according to a predetermined rule, m a chromatography step of adding the nth supernatant component separated by the stepwise centrifugation step to a size exclusion chromatography column, and then supplying a buffer to the column at a predetermined flow rate, where b is a predetermined integer, and discharging the nth supernatant component and the buffer as a mixture of the supernatant component and the buffer from the column as a chromatography sample, and recovering the chromatography sample discharged from the column in amounts according to a predetermined rule to fractionate the sample into b fractions, wherein the method for separating and fractionating a biological sample comprises the steps of:
2. x m and y are each a predetermined integer, in the density gradient centrifugation recovery step corresponding to the m pellet component, the density gradient reagent is added in an amount of x m ml each evenly m 2. The method for separating and fractionating a biological sample according to claim 1, wherein the chromatography sample discharged from the column is equally fractionated into b fractions each of y ml.
3. x m The method for separating and fractionating a biological sample according to claim 2 , wherein:
4. When using a 14 ml density gradient centrifugation tube, x m = y = 1 ml, and a m The method for separating and fractionating a biological sample according to claim 3, wherein a=14 and b=30.
5. The method for separating and fractionating a biological sample according to claim 1, wherein n is 3 and three centrifugation processes are performed.
6. The method for separating and fractionating a biological sample according to claim 1, wherein the density gradient reagent is an iodixanol solution.
7. A method for separating and fractionating a biological sample as described in claim 6, wherein the maximum value of the concentration of the density gradient reagent used when performing the density gradient centrifugation process on the (m+1)th pellet component is set to be greater than the minimum value of the concentration of the density gradient reagent used when performing the density gradient centrifugation process on the mth pellet component.
8. The method for separating and fractionating a biological sample according to claim 5, wherein the density gradient reagent is an iodixanol solution.
9. The method for separating and fractionating a biological sample according to claim 8, wherein the density gradient reagent is formed by layering the iodixanol solution at six different concentrations.
10. A method for separating and fractionating a biological sample as described in claim 9, wherein the density gradient reagent used when performing the density gradient centrifugation process on the second pellet component is layered from the bottom up so that the concentrations of the iodixanol solution are 35%, 30%, 25%, 22.5%, 20% and 15%, and the density gradient reagent used when performing the density gradient centrifugation process on the third pellet component is layered from the bottom up so that the concentrations of the iodixanol solution are 25%, 20%, 15%, 10%, 5% and 0%.
11. The method for separating and fractionating a biological sample according to claim 1, wherein a plurality of columns connected in series are used in the chromatography step.
12. The method for separating and fractionating a biological sample according to claim 11, wherein two columns connected in series are used in the chromatography step.
13. A method for separating and fractionating a biological sample according to any one of claims 1 to 12, wherein the fractions obtained in each step are automatically separated and collected by a fraction collector.
Citation Information
Patent Citations
Treatment or prevention of psychiatric disease based on KIF3 motor, and drug screening
WO2021100685A1
